Revision as of 14:43, 18 June 2014 editKhabboos (talk | contribs)1,384 edits →For your enjoyment← Previous edit | Revision as of 14:59, 18 June 2014 edit undoKhabboos (talk | contribs)1,384 edits →Positive studies and clinical trials: new sectionNext edit → | ||
Line 168: | Line 168: | ||
::I got a request to sign a petition from change.org to avoid the Homeopathic section's closure at the Bristol (or was it Glasgow?) Hospital which claimed that a petition for it's closure was signed by 2000 sceptics/critics of Homeopathy, while they have 24,000 signatures to avoid its closure and were looking to make it 25,000 signatures. However, are we at wikipedia going to put such trivia into this article? I hope not!—] (]) 14:43, 18 June 2014 (UTC) | ::I got a request to sign a petition from change.org to avoid the Homeopathic section's closure at the Bristol (or was it Glasgow?) Hospital which claimed that a petition for it's closure was signed by 2000 sceptics/critics of Homeopathy, while they have 24,000 signatures to avoid its closure and were looking to make it 25,000 signatures. However, are we at wikipedia going to put such trivia into this article? I hope not!—] (]) 14:43, 18 June 2014 (UTC) | ||
== Positive studies and clinical trials == | |||
<b> | |||
<p align="left">STUDIES OF THE ACTIVITY OF HOMEOPATHIC MEDICINES</p> | |||
<div align="left"> | |||
<table height="172" width="678" border="1"> | |||
<tbody> | |||
<tr> | |||
<td width="171" height="9"><font size="1">ORIGINAL/TRANSLATED TITLE</font></td> | |||
<td width="128" height="9">AUTHOR(S)</td> | |||
<td width="84" height="9">PUBLICATION</td> | |||
<td width="92" height="9">ACTIVITY</td> | |||
<td width="203" height="9">STUDY</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="9"><font face="Optima-Bold" size="1"><b> | |||
<p align="left">Inhibition of lymphoblast</b></font></b> <font face="Optima-Bold" size="1"><b>transformation | |||
test (LTT) in</b></font> <font face="Optima-Bold" size="1"><b>phytohaemagglutinin | |||
(PHA) with</b></font> <font face="Optima-Bold" size="1"><b>Phytolacca | |||
americana in</b></font> <b><font face="Optima-Bold" size="1">homeopathic | |||
dilution</font></b></p> | |||
</td> | |||
<td width="128" height="9"><font face="Optima" size="1"> | |||
<p align="left">Colas H.,</p> | |||
<p align="left">Aubin M.,</p> | |||
<p align="left">Picard P.,</p> | |||
<p align="left">Lebecq J.C.</font></p> | |||
</td> | |||
<td width="84" height="9"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Ann. Homéopat.</p> | |||
<p align="left">Fr.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1975</font></b><font face="Optima" size="1">, | |||
6: 1-11.</font></p> | |||
</td> | |||
<td width="92" height="9"><b> | |||
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p> | |||
</td> | |||
<td width="203" height="9"> | |||
<p align="left"><font face="Optima" size="1">Lymphoblast</p> | |||
<p align="left">transformation</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="9"><font face="Optima-Bold" size="1"><b> | |||
<p align="left">Inquiry into the limits of biological</b></font> <font face="Optima-Bold" size="1"><b>effects | |||
of chemical compounds in</b></font> <font face="Optima-Bold" size="1"><b>tissue | |||
culture. I. Low dose effects of</b></font> <b><font face="Optima-Bold" size="1">mercure | |||
chloride</font></b></p> | |||
</td> | |||
<td width="128" height="9"><font face="Optima" size="1"> | |||
<p align="left">Mansvelt J.D.,</p> | |||
<p align="left">van Amons E.</font></p> | |||
</td> | |||
<td width="84" height="9"> | |||
<p align="left"><i><font face="Optima-Oblique" size="1">Z. | |||
Naturtorschung</font></i><font face="Optima" size="1">,</p> | |||
</font><b><font face="Optima-Bold" size="1"> | |||
<p align="left">1975</font></b><font face="Optima" size="1">, 30:</p> | |||
<p align="left">643-649.</font></p> | |||
</td> | |||
<td width="92" height="9"><b> | |||
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p> | |||
</td> | |||
<td width="203" height="9"><font face="Optima" size="1"> | |||
<p align="left">Lymphocyte</p> | |||
<p align="left">growth</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="9"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">The effects of Belladonna and</font></b> <font face="Optima-Bold" size="1"><b>Ferrum | |||
phosphoricum on the</b></font> <font face="Optima-Bold" size="1"><b>chemoluminescence | |||
of human</b></font> <b><font face="Optima-Bold" size="1">poly-morphonuclear | |||
neutrophils</font></b></p> | |||
</td> | |||
<td width="128" height="9"><font face="Optima" size="1"> | |||
<p align="left">Poitevin B.,</p> | |||
<p align="left">Aubin M.,</p> | |||
<p align="left">Royer J.F.</font></p> | |||
</td> | |||
<td width="84" height="9"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Ann. Homéop. Fr.</font></i><font face="Optima" size="1">,</p> | |||
</font><b><font face="Optima-Bold" size="1"> | |||
<p align="left">1983</font></b><font face="Optima" size="1">, 3: 5-12.</font></p> | |||
</td> | |||
<td width="92" height="9"><b> | |||
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p> | |||
</td> | |||
<td width="203" height="9"><font face="Optima" size="1">Radical release</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Effect of aconitum and veratrum</p> | |||
<p align="left">on the isolated perfused heart of</p> | |||
<p align="left">the common eel </font></b><font face="Optima" size="1">(Anguilla | |||
anguilla)</font></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Pennec J.P.,</p> | |||
<p align="left">Aubin M.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Comp. Biochem.</p> | |||
<p align="left">Physiol.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1984</font></b><font face="Optima" size="1">,</p> | |||
<p align="left">776: 367-369.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1">Aconitine toxicity</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Elements of homeopathic</p> | |||
<p align="left">pharmacology</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Aubin M.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Homéopathie</p> | |||
<p align="left">Franç.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1984</font></b><font face="Optima" size="1">, | |||
72:</p> | |||
<p align="left">231- 235</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1">Aconitine toxicity</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">The effect of homeopathic</p> | |||
<p align="left">preparations on the phagocyte</p> | |||
<p align="left">activity of granulocytes. In vitro</p> | |||
<p align="left">tests and double-blind controlled</p> | |||
<p align="left">trials</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Wagner H.,</p> | |||
<p align="left">Jurcic K.,</p> | |||
<p align="left">Doenicke A.,</p> | |||
<p align="left">Rosenhuber E.,</p> | |||
<p align="left">Behrens N.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Arzneim.</p> | |||
<p align="left">Forsch./Drug Res.</font></i><font face="Optima" size="1">,</p> | |||
</font><b><font face="Optima-Bold" size="1"> | |||
<p align="left">1986</font></b><font face="Optima" size="1">, 36:</p> | |||
<p align="left">1424-1425.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1">Phagocytosis</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Approach to quantitative analysis</p> | |||
<p align="left">of the effect of Apis mellifica on</p> | |||
<p align="left">the degranulation of human</p> | |||
<p align="left">basophils cultivated in vitro</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Poitevin B.,</p> | |||
<p align="left">Aubin M.,</p> | |||
<p align="left">Benveniste J.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Innov. Tech. Biol.</p> | |||
<p align="left">Med.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1986</font></b><font face="Optima" size="1">, | |||
7:</p> | |||
<p align="left">64-68.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Basophil</p> | |||
<p align="left">degranulation</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">In vitro stimulation of human</font></b> <b><font face="Optima-Bold" size="1">granulocytes | |||
and lymphocytes by</font></b> <font face="Optima-Bold" size="1"><b>pico- | |||
and femtogram quantities of</b></font> <b><font face="Optima-Bold" size="1">cytostatic | |||
agents</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Wagner H.,</p> | |||
<p align="left">Kreher B.,</p> | |||
<p align="left">Jurcic K.</font></p> | |||
</td> | |||
<td width="84" height="8"><font face="Optima-Oblique" size="1"><i> | |||
<p align="left">Arzneim.</i></font> <b><font face="Optima-Oblique" size="1"><i>Forsch./Drug | |||
Res.</i></font><font face="Optima" size="1">,</font></b> <b><font face="Optima-Bold" size="1">1988</font><font face="Optima" size="1">, | |||
38:</font></b> <b><font face="Optima" size="1">273-275.</font></b></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Lymphocyte</p> | |||
<p align="left">growth</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><font face="Optima" size="1"> | |||
<p align="left"></font><b><font face="Optima-Bold" size="1">In vitro | |||
immunological</p> | |||
<p align="left">degranulation of human basophils</p> | |||
<p align="left">is modulated by lung histamine</p> | |||
<p align="left">and Apis mellifica</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Poitevin B.,</p> | |||
<p align="left">Davenas E.,</p> | |||
<p align="left">Benveniste J.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Brit. J. Clin.</p> | |||
<p align="left">Pharmacol.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1988</font></b><font face="Optima" size="1">,</p> | |||
<p align="left">25: 439-444.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Basophil</p> | |||
<p align="left">degranulation</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Cytotoxic agents as</p> | |||
<p align="left">immunomodulators</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Wagner H.,</p> | |||
<p align="left">Kreher B.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Proc. of the 3rd</p> | |||
<p align="left">GIRI meeting</font></i><font face="Optima" size="1">,</p> | |||
<p align="left">Paris, </font><b><font face="Optima-Bold" size="1">1989</font></b><font face="Optima" size="1">, | |||
31-</p> | |||
<p align="left">46.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Lymphocyte</p> | |||
<p align="left">growth</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Contributions of fundamental</p> | |||
<p align="left">research in homeopathy</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Boiron J.,</p> | |||
<p align="left">Belon P.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Berl. J. Res. Hom.</font></i><font face="Optima" size="1">,</p> | |||
</font><b><font face="Optima-Bold" size="1"> | |||
<p align="left">1990</font></b><font face="Optima" size="1">, 1: 34-35.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Basophil</p> | |||
<p align="left">degranulation</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Synergism of action between</p> | |||
<p align="left">indoleacetic acid (IAA) and highly</p> | |||
<p align="left">diluted solutions of CaCO3 on the</p> | |||
<p align="left">growth of oat coleoptiles</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1">Bornoroni C.</font></td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Berl. J. Res. Hom.</font></i><font face="Optima" size="1">,</p> | |||
</font><b><font face="Optima-Bold" size="1"> | |||
<p align="left">1991</font></b><font face="Optima" size="1">, 1 (4/5):</p> | |||
<p align="left">275-278.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Growth of plant</p> | |||
<p align="left">cells</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Study of the action of</p> | |||
<p align="left">Hahnemannian dilutions of</p> | |||
<p align="left">mercury chloride on the mitotic</p> | |||
<p align="left">index in animal cell cultures.</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Boiron J.,</p> | |||
<p align="left">Abecassis J.,</p> | |||
<p align="left">Cotte J.,</p> | |||
<p align="left">Bernard A.M.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Ann. Homéop.</p> | |||
<p align="left">Fr</font></i><font face="Optima" size="1">., </font><b><font face="Optima-Bold" size="1">1991</font></b><font face="Optima" size="1">, | |||
23:</p> | |||
<p align="left">43-49.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1">Hg toxicity</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Dual effects of formylpeptides on</p> | |||
<p align="left">the adhesion of endotoxin-primed</p> | |||
<p align="left">human neutrophils</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Bellavite P.,</p> | |||
<p align="left">Chirumbolo S.,</p> | |||
<p align="left">Lippi G.,</p> | |||
<p align="left">Andrioli G.,</p> | |||
<p align="left">Bonazzi L.,</p> | |||
<p align="left">Ferro I.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Cell. Biochem.</p> | |||
<p align="left">Funct.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">, | |||
11:</p> | |||
<p align="left">231-239.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Cell adhesion</p> | |||
<p align="left">(bact. pept.</p> | |||
<p align="left">10-8-10-9)</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Effects of homeopathic</p> | |||
<p align="left">preparations of organic acids and</p> | |||
<p align="left">of minerals on the oxidative</p> | |||
<p align="left">metabolism of human neutrophils</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Chirumbolo S.,</p> | |||
<p align="left">Signorini A.,</p> | |||
<p align="left">Bianchi I.,</p> | |||
<p align="left">Lippi G.,</p> | |||
<p align="left">Bellavite P.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Br. Hom. J.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">,</p> | |||
<p align="left">82: 227-244.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Leucocyte</p> | |||
<p align="left">activation</p> | |||
<p align="left">(metabolism)</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Platelets/endothelial cells</p> | |||
<p align="left">interactions in presence of</p> | |||
<p align="left">acetylsalicylic acid at ultra low</p> | |||
<p align="left">dose</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Doutremepuich</p> | |||
<p align="left">C.,</p> | |||
<p align="left">Lalanne M.C.,</p> | |||
<p align="left">Ramboer I.,</p> | |||
<p align="left">Sertillanges</p> | |||
<p align="left">M.N.,</p> | |||
<p align="left">De Seze O.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Omeomed 92 (C.</p> | |||
<p align="left">Bornoroni, ed.)</font></i><font face="Optima" size="1">,</p> | |||
</font><b><font face="Optima-Bold" size="1"> | |||
<p align="left">1993</font></b><font face="Optima" size="1">, Editrice</p> | |||
<p align="left">Compositori,</p> | |||
<p align="left">Bologna:</p> | |||
<p align="left">109-115.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Prostacyclin</p> | |||
<p align="left">release</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Effect of high dilutions of epidermal</p> | |||
<p align="left">growth factor (EGF) on </font><i><font face="Optima-BoldOblique" size="1">in | |||
vitro</p> | |||
</font></i><font face="Optima-Bold" size="1"> | |||
<p align="left">proliferation of keratinocyte and</p> | |||
<p align="left">fibroblast cell lines</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Fougeray S.,</p> | |||
<p align="left">Moubry K.,</p> | |||
<p align="left">Vallot N.,</p> | |||
<p align="left">Bastide M.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Br. Hom. J.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">,</p> | |||
<p align="left">82: 124-125.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Growth of</p> | |||
<p align="left">keratinocytes</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Effects of different homeopathic</p> | |||
<p align="left">potencies of Lachesis on</p> | |||
<p align="left">lymphocyte cultures obtained</p> | |||
<p align="left">from rabbit blood</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Enbergs H.,</p> | |||
<p align="left">Arndt G.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Biol. Tier., </font><b><font face="Optima-BoldOblique" size="1">1993</font></b><font face="Optima-Oblique" size="1">,</p> | |||
<p align="left">4.</font></i></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Mitotic and</p> | |||
<p align="left">immunostimulating</p> | |||
<p align="left">activity (bact. pept</p> | |||
<p align="left">10-5-10-6)</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">The effect of homeopathic</p> | |||
<p align="left">potencies of housedust mite on</p> | |||
<p align="left">the migration of house-dust sensitive</p> | |||
<p align="left">human leukocytes</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Gibson S.L.,</p> | |||
<p align="left">Gibson R.G.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Complement.</p> | |||
<p align="left">Ther. Med.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1996</font></b><font face="Optima" size="1">,</p> | |||
<p align="left">4: 169-171.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Leucocyte</p> | |||
<p align="left">chemotaxis</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">The effects of Nux vomica</p> | |||
<p align="left">Homaccord and Atropinum comp.</p> | |||
<p align="left">on intestinal activity in vitro</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Kanui T.I.,</p> | |||
<p align="left">Enbergs H.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Biol. Tier.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1996</font></b><font face="Optima" size="1">/1,</p> | |||
<p align="left">43-47.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Contraction of</p> | |||
<p align="left">intestinal muscles</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Application of flow cytometry to</p> | |||
<p align="left">the analysis of the</p> | |||
<p align="left">immunosuppressive effect of</p> | |||
<p align="left">histamine dilutions on human</p> | |||
<p align="left">basophil action: effect of</p> | |||
<p align="left">cimetidine</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Sainte-Laudy J.,</p> | |||
<p align="left">Belon P.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Inflamm. Res</font></i><font face="Optima" size="1">.,</p> | |||
</font><b><font face="Optima-Bold" size="1"> | |||
<p align="left">1997</font></b><font face="Optima" size="1">, 46:</p> | |||
<p align="left">S27-S28.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Basophil</p> | |||
<p align="left">degranulation</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Effects of Podophillum pellatum</p> | |||
<p align="left">compounds in various</p> | |||
<p align="left">preparations and dilutions on</p> | |||
<p align="left">human neutrophil functions in</p> | |||
<p align="left">vitro</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Chirumbolo S.,</p> | |||
<p align="left">Conforti A.,</p> | |||
<p align="left">Lussignoli S.,</p> | |||
<p align="left">Metelmann H.</p> | |||
<p align="left">et Al.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Br. Hom. J</font></i><font face="Optima" size="1">., </font><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">;</p> | |||
<p align="left">86-16.</font></p> | |||
</td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Release of</p> | |||
<p align="left">superoxides</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><i><font face="Optima-BoldOblique" size="1"> | |||
<p align="left">In vivo </font></i><font face="Optima-Bold" size="1">and | |||
</font><i><font face="Optima-BoldOblique" size="1">in vitro </font></i><font face="Optima-Bold" size="1">studies | |||
on the</p> | |||
<p align="left">efficiency of potentized and nonpotentized</p> | |||
<p align="left">substances</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Harisch G.,</p> | |||
<p align="left">Dittmann J.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BT, </font></i><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">, | |||
2;</p> | |||
<p align="left">40-46.</font></p> | |||
</td> | |||
<td width="92" height="8"><font face="Optima" size="1"> | |||
<p align="left">Difference between</p> | |||
<p align="left">potentised and</p> | |||
<p align="left">non-potentised</p> | |||
<p align="left">substances</font></p> | |||
</td> | |||
<td width="203" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">In vivo </font></i><font face="Optima" size="1">and </font><i><font face="Optima-Oblique" size="1">in</p> | |||
<p align="left">vitro </font></i><font face="Optima" size="1">study; | |||
basic</p> | |||
<p align="left">research</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Experiments with the effects of</p> | |||
<p align="left">Ubichinon-Injeel and strong</p> | |||
<p align="left">Ubichinon-Injeel on an acellular</p> | |||
<p align="left">system</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Harisch G.,</p> | |||
<p align="left">Dittmann J.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">, | |||
3;</p> | |||
<p align="left">99-104.</font></p> | |||
</td> | |||
<td width="92" height="8"><font face="Optima" size="1"> | |||
<p align="left">Different effects of</p> | |||
<p align="left">associations of</p> | |||
<p align="left">various potencies and</p> | |||
<p align="left">individual potencies</font></p> | |||
</td> | |||
<td width="203" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p> | |||
<p align="left">basic research</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Efficacy of the homeopathic drugs</p> | |||
<p align="left">Suis and Arnica comp.-Heel® on</p> | |||
<p align="left">lymphocyte and phagocyte</p> | |||
<p align="left">activity</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1">Enbergs H.</font></td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">, | |||
1;</p> | |||
<p align="left">3-11.</font></p> | |||
</td> | |||
<td width="92" height="8"><font face="Optima" size="1"> | |||
<p align="left">Effect of</p> | |||
<p align="left">organotherapeutics</p> | |||
<p align="left">and Arnica comp. -</p> | |||
<p align="left">Heel® on immune</p> | |||
<p align="left">system cells</font></p> | |||
</td> | |||
<td width="203" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p> | |||
<p align="left">basic research</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Influence of dilutions and</p> | |||
<p align="left">potencies of cAMP on different</p> | |||
<p align="left">enzymatic systems</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Harisch G.,</p> | |||
<p align="left">Dittmann J.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">, | |||
2;</p> | |||
<p align="left">55-62.</font></p> | |||
</td> | |||
<td width="92" height="8"><font face="Optima" size="1"> | |||
<p align="left">Effects of dilutions</p> | |||
<p align="left">and potencies of</p> | |||
<p align="left">cAMP on some</p> | |||
<p align="left">enzymatic activities</font></p> | |||
</td> | |||
<td width="203" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p> | |||
<p align="left">basic research</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Studies of the principles of</p> | |||
<p align="left">homeopathy; the changeover</p> | |||
<p align="left">from </font><i><font face="Optima-BoldOblique" size="1">in | |||
vivo </font></i><font face="Optima-Bold" size="1">to </font><i><font face="Optima-BoldOblique" size="1">in | |||
vitro</p> | |||
</font></i><font face="Optima-Bold" size="1"> | |||
<p align="left">experimental research</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Harisch G.,</p> | |||
<p align="left">Dittmann J.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">, | |||
3;</p> | |||
<p align="left">98-103.</font></p> | |||
</td> | |||
<td width="92" height="8"><font face="Optima" size="1"> | |||
<p align="left">Potentised and</p> | |||
<p align="left">non-potentised</p> | |||
<p align="left">dilutions are</p> | |||
<p align="left">equally effective,</p> | |||
<p align="left">but have different</p> | |||
<p align="left">actions</font></p> | |||
</td> | |||
<td width="203" height="8"> | |||
<p align="left"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic | |||
research</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><font face="Optima-Bold" size="1"><b> | |||
<p align="left">Determination of the activity of</b></font> <b><font face="Optima-Bold" size="1">acid | |||
phosphatase with cAMP at</font></b> <b><font face="Optima-Bold" size="1">various | |||
potencies</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Harisch G.,</p> | |||
<p align="left">Dittmann J.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">, | |||
1; 4-8.</font></td> | |||
<td width="92" height="8"><font face="Optima" size="1"> | |||
<p align="left">Different effects on</font> <font face="Optima" size="1">enzymatic | |||
activity</font></p> | |||
</td> | |||
<td width="203" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p> | |||
<p align="left">basic research</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Contribution to study of the</p> | |||
<p align="left">efficacy of homeopathic potencies</p> | |||
<p align="left">of phosphorus</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1">Gomez J.C.</font></td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BT, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">, | |||
2;</p> | |||
<p align="left">53-57.</font></p> | |||
</td> | |||
<td width="92" height="8"><font face="Optima" size="1"> | |||
<p align="left">Effect of different</p> | |||
<p align="left">potencies of</p> | |||
<p align="left">phosphorus</font></p> | |||
</td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Tests on guinea</p> | |||
<p align="left">pigs</font></p> | |||
</td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Determination of the activity of</p> | |||
<p align="left">acid phosphatase in the presence</p> | |||
<p align="left">of Ubichinon comp.</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Harisch G.,</p> | |||
<p align="left">Dittmann J.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">, | |||
4;</p> | |||
<p align="left">188-194.</font></p> | |||
</td> | |||
<td width="92" height="8"><font face="Optima" size="1"> | |||
<p align="left">Effect of enzymatic</p> | |||
<p align="left">activity of</p> | |||
<p align="left">homeopathic</p> | |||
<p align="left">medicine</font></p> | |||
</td> | |||
<td width="203" height="8"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic | |||
research</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Biochemical efficacy of</p> | |||
<p align="left">homeopathic and electronic</p> | |||
<p align="left">preparations of D8 potassium</p> | |||
<p align="left">cyanate</font></b></p> | |||
</td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Dittmann J.,</p> | |||
<p align="left">Kanapin H.,</p> | |||
<p align="left">Harisch G.</font></p> | |||
</td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">FKM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">, | |||
6;</p> | |||
<p align="left">15-18.</font></p> | |||
</td> | |||
<td width="92" height="8"><font face="Optima" size="1"> | |||
<p align="left">Homeopathic</p> | |||
<p align="left">potentisation is</p> | |||
<p align="left">more effective than</p> | |||
<p align="left">electronic</p> | |||
<p align="left">potentisation</font></p> | |||
</td> | |||
<td width="203" height="8"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic | |||
research</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Osteoporosis in vitro in rat tibiaderived</p> | |||
<p align="left">osteoblasts is promoted</p> | |||
<p align="left">by the homeopathic preparation,</p> | |||
<p align="left">FMS Calciumfluor</font></b></td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Palermo C.,</p> | |||
<p align="left">Filanti C.,</p> | |||
<p align="left">Poggi S.,</p> | |||
<p align="left">Manduca P.</font></td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Cell Biol Int</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,</p> | |||
<p align="left">23(1): 31-40.</font></td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Stimulant</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Osteogenesis</p> | |||
<p align="left">(trial with</p> | |||
<p align="left">compound drug)</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="32" rowspan="2"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Thin-layer chromatography (TLC)</p> | |||
<p align="left">of homeopathic active</p> | |||
<p align="left">constituents</font></b></td> | |||
<td width="128" height="32" rowspan="2"><font face="Optima" size="1">Schmolz | |||
M.</font></td> | |||
<td width="84" height="32" rowspan="2"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">, | |||
5;</p> | |||
<p align="left">248-250.</font></td> | |||
<td width="92" height="16"><font face="Optima" size="1"> | |||
<p align="left">Constituents of</font> <font face="Optima" size="1">Arnica | |||
comp.-</font> <font face="Optima" size="1">Heel® ointment:</font> <font face="Optima" size="1">electrophoresis</font> | |||
<font face="Optima" size="1">accelerates their</font> <font face="Optima" size="1">skin | |||
penetration.</font> </td> | |||
<td width="203" height="32"><font face="Optima" size="1">Basic research</font></td> | |||
</tr> | |||
<tr> | |||
<td width="92" height="16"><font face="Optima" size="1">Effect of</font> <font face="Optima" size="1">homeopathic</font> | |||
<font face="Optima" size="1">constituents on</font> <font face="Optima" size="1">enzymatic | |||
activity.</font></td> | |||
<td width="203" height="4"><font face="Optima" size="1">Basic research</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Efficacy of a potentised</p> | |||
<p align="left">homeopathic drug in reducing</p> | |||
<p align="left">cytotoxic effects produced by</p> | |||
<p align="left">arsenic trioxide in mice</font></b></td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Datta S.,</p> | |||
<p align="left">Mallick P.,</p> | |||
<p align="left">Bukhsh A.R.</font></td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Complement Ther</p> | |||
<p align="left">Med</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999 | |||
</font></b><font face="Optima" size="1">Jan;</p> | |||
<p align="left">7 (8): 62-75 </font><b><font face="Optima-Bold" size="1">(a).</font></b></td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Arsenic trioxide</p> | |||
<p align="left">toxicity</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Efficacy of a potentised</p> | |||
<p align="left">homeopathic drug in reducing</p> | |||
<p align="left">cytotoxic effects produced by</p> | |||
<p align="left">arsenic trioxide in mice</font></b></td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Datta S.,</p> | |||
<p align="left">Mallick P.,</p> | |||
<p align="left">Bukhsh A.R.</font></td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Complement Ther</p> | |||
<p align="left">Med</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999 | |||
</font></b><font face="Optima" size="1">Sep;</p> | |||
<p align="left">7 (3): 156-63 </font><b><font face="Optima-Bold" size="1">(b).</font></b></td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Arsenic trioxide</p> | |||
<p align="left">toxicity</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><font face="Optima-Bold" size="1"><b> | |||
<p align="left">Non-cytotoxic antiviral action of</b></font> <font face="Optima-Bold" size="1"><b>a | |||
homeopathic drug</b></font></td> | |||
<td width="128" height="8"><font face="Optima" size="1">Heine H.</font></td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Ärzteitschrift für</p> | |||
<p align="left">Neturheilverfahre</font></i><font face="Optima" size="1">,</p> | |||
</font><b><font face="Optima-Bold" size="1"> | |||
<p align="left">2000</font></b><font face="Optima" size="1">; 41: 542-7.</font></td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> | |||
<td width="203" height="8"><font face="Symbol" size="1"> | |||
<p align="left">γ </font><font face="Optima" size="1">interferon</p> | |||
<p align="left">synthesis</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Efficacy of a potentised</p> | |||
<p align="left">homeopathic drug in reducing</p> | |||
<p align="left">cytotoxic effects produced by</p> | |||
<p align="left">arsenic trioxide in mice</font></b></td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Kundu S.N.,</p> | |||
<p align="left">Mitra K.,</p> | |||
<p align="left">Khuda</p> | |||
<p align="left">Bukhsh A.R.</font></td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Complement Ther</p> | |||
<p align="left">Med </font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">2000 | |||
</font></b><font face="Optima" size="1">Sep;</p> | |||
<p align="left">1 (3): 157-65.</font></td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Arsenic trioxide</p> | |||
<p align="left">toxicity</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Stimulatory effect of some plant</p> | |||
<p align="left">extracts used in homeopathy on</p> | |||
<p align="left">the phagocytosis induced</p> | |||
<p align="left">chemiluminescence of</p> | |||
<p align="left">polymorphonuclear leukocytes</font></b></td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Crocnan D.,</p> | |||
<p align="left">Greabu M.,</p> | |||
<p align="left">Olinescu R.</font></td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Rocz Akad Med</p> | |||
<p align="left">Biochemist</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">;</p> | |||
<p align="left">45: 246-254.</font></td> | |||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> | |||
<td width="203" height="8"><font face="Optima" size="1"> | |||
<p align="left">Phagocytosis</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Difference between the efficacy</p> | |||
<p align="left">of single potencies and chords</font></b></td> | |||
<td width="128" height="8"><font face="Optima" size="1"> | |||
<p align="left">Dittmann J.,</p> | |||
<p align="left">Harisch G.</font></td> | |||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">, | |||
1;</p> | |||
<p align="left">18-23.</font></td> | |||
<td width="92" height="8"><font face="Optima" size="1"> | |||
<p align="left">Potency chords are</p> | |||
<p align="left">more effective than</p> | |||
<p align="left">single potencies</font></td> | |||
<td width="203" height="8"><font face="Optima" size="1">Basic research</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="28"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Influence of some homeopathic</p> | |||
<p align="left">drugs on the catalytic activity of</p> | |||
<p align="left">uricase, acid phosphatase and the</p> | |||
<p align="left">cytosol glutathion-S-transferase</font></b></td> | |||
<td width="128" height="28"><font face="Optima" size="1"> | |||
<p align="left">Dittmann J.,</p> | |||
<p align="left">Kanapin H.,</p> | |||
<p align="left">Harisch G.</font></td> | |||
<td width="84" height="28"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">, | |||
3;</p> | |||
<p align="left">125-131</font></td> | |||
<td width="92" height="28"><font face="Optima" size="1"> | |||
<p align="left">Effect of D8</p> | |||
<p align="left">potencies on three</p> | |||
<p align="left">different enzymatic</p> | |||
<p align="left">systems</font></td> | |||
<td width="203" height="28"><font face="Optima" size="1">Basic research</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="37"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Influence of some homeopathic</p> | |||
<p align="left">drugs on the catalytic activity of</p> | |||
<p align="left">cAMP-dependent protein kinases</font></b></td> | |||
<td width="128" height="37"><font face="Optima" size="1"> | |||
<p align="left">Dittmann J.,</p> | |||
<p align="left">Kanapin H.,</p> | |||
<p align="left">Harisch G.</font></td> | |||
<td width="84" height="37"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">, | |||
6;</p> | |||
<p align="left">289-296.</font></td> | |||
<td width="92" height="37"><font face="Optima" size="1"> | |||
<p align="left">Effect of different</p> | |||
<p align="left">potencies of 5</p> | |||
<p align="left">substances on</p> | |||
<p align="left">enzymatic activity</font></td> | |||
<td width="203" height="37"><font face="Optima" size="1">Basic research</font></td> | |||
</tr> | |||
<tr> | |||
<td width="171" height="38"><b><font face="Optima-Bold" size="1"> | |||
<p align="left">Neuroprotection from glutamate</p> | |||
<p align="left">toxicity with ultra-low dose</p> | |||
<p align="left">glutamate</font></b></td> | |||
<td width="128" height="38"> | |||
<p align="left"><font face="Optima" size="1">Jonas W.,</p> | |||
<p align="left">Lin Y.,</p> | |||
<p align="left">Zortella F.</font></td> | |||
<td width="84" height="38"><i><font face="Optima-Oblique" size="1"> | |||
<p align="left">Neuroreport</font></i><font face="Optima" size="1">,</p> | |||
</font><b><font face="Optima-Bold" size="1"> | |||
<p align="left">2001 </font></b><font face="Optima" size="1">Feb 92; 12</p> | |||
<p align="left">(2): 335-9.</font></td> | |||
<td width="92" height="38"><b><font face="Optima-Bold" size="1">Protective</font></b></td> | |||
<td width="203" height="38"><font face="Optima" size="1">Glutamate | |||
toxicity</font></td> | |||
</tr> | |||
</tbody> | |||
</table> | |||
</div> | |||
<font face="Optima" size="1"> | |||
<p align="left"> </p> | |||
<p align="left">KEY: BT = Biomedical Therapy</p> | |||
<p align="left">BM = Biologische Medizin</p> | |||
<p align="left">FKM = Forschung Komplementär Medizin</p> | |||
</font> |
Revision as of 14:59, 18 June 2014
Skip to table of contents |
This is the talk page for discussing improvements to the Homeopathy article. This is not a forum for general discussion of the article's subject. |
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: Index, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65Auto-archiving period: 30 days |
The contentious topics procedure applies to this page. This page is related to pseudoscience and fringe science, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Misplaced Pages, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
Arbitration Ruling on the Treatment of Pseudoscience
In December of 2006 the Arbitration Committee ruled on guidelines for the presentation of topics as pseudoscience in Misplaced Pages:Requests for arbitration/Pseudoscience. The final decision was as follows:
|
The subject of this article is controversial and content may be in dispute. When updating the article, be bold, but not reckless. Feel free to try to improve the article, but don't take it personally if your changes are reversed; instead, come here to the talk page to discuss them. Content must be written from a neutral point of view. Include citations when adding content and consider tagging or removing unsourced information. |
Important notice: Some common points of argument are addressed in the FAQ below, which represents the consensus of editors here. Please remember that this page is only for discussing Misplaced Pages's encyclopedia article about Homeopathy. |
view · edit Frequently asked questions
Some common points of argument are addressed in the FAQ below, which represents the consensus of editors here. Please remember that this page is only for discussing Misplaced Pages's encyclopedia article about Homeopathy. To view an explanation to the answer, click the link to the right of the question. Q1: Should material critical of homeopathy be in the article? (Yes.) A1: Yes. Material critical of homeopathy must be included in the article. The articles on Misplaced Pages include information from all significant points of view. This is summarized in the policy pages which can be accessed from the Neutral point of view policy. This article strives to conform to Misplaced Pages policies, which dictate that a substantial fraction of articles in fringe areas be devoted to mainstream views of those topics. Q2: Should material critical of homeopathy be in the lead? (Yes.) A2: Yes. Material critical of homeopathy belongs in the lead section. The lead must contain a summary of all the material in the article, including the critical material. This is described further in the Lead section guideline. Q3: Is the negative material in the article NPOV? (Yes.) A3: Yes. Including negative material is part of achieving a neutral article. A neutral point of view does not necessarily equate to a sympathetic point of view. Neutrality is achieved by including all points of view – both positive and negative – in rough proportion to their prominence. Q4: Does Misplaced Pages consider homeopathy a fringe theory? (Yes.) A4: Yes. Homeopathy is described as a fringe medical system in sources reliable to make the distinction. This is defined by the Fringe theories guideline, which explains: We use the term fringe theory in a very broad sense to describe ideas that depart significantly from the prevailing or mainstream view in its particular field of study.Since the collective weight of peer-reviewed studies does not support the efficacy of homeopathy, it departs significantly enough from the mainstream view of science to be considered a fringe theory. References
|
Homeopathy was one of the Natural sciences good articles, but it has been removed from the list. There are suggestions below for improving the article to meet the good article criteria. Once these issues have been addressed, the article can be renominated. Editors may also seek a reassessment of the decision if they believe there was a mistake. | ||||||||||||||||||||||||||||||||||||||||
|
This article has not yet been rated on Misplaced Pages's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
{{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
{{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
{{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
|
There have been attempts to recruit editors of specific viewpoints to this article, in a manner that does not comply with Misplaced Pages's policies. Editors are encouraged to use neutral mechanisms for requesting outside input (e.g. a "request for comment", a third opinion or other noticeboard post, or neutral criteria: "pinging all editors who have edited this page in the last 48 hours"). If someone has asked you to provide your opinion here, examine the arguments, not the editors who have made them. Reminder: disputes are resolved by consensus, not by majority vote. |
Archives |
Index 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 |
This page has archives. Sections older than 30 days may be automatically archived by Lowercase sigmabot III when more than 1 section is present. |
Pseodoscience
The article calls homeopathy a pseudoscience, but nowhere in wikipedia's guidelines does this seem to be allowed. Misplaced Pages:Fringe_theories There is no scientific consensus that homeopathy is pseudoscience, especially in Europe, therefore, it is classified as a questionable science. Klocek (talk) 12:11, 25 May 2014 (UTC)
- It's not explicitly stated, in the Misplaced Pages guidelines that anything should be called anything. The thing is that there is nothing in the guidelines that says it shouldn't be - and anything that's not forbidden is OK. What we ARE required to do is to represent the world from a mainstream scientific perspective and to provide references for what we say.
- The mainstream scientific view is that Homeopathy is a pseudoscience...and we have references to prove that. So there is no reason we shouldn't say so. More importantly, the WP:FRINGE guidelines make it clear that it would be a breach of the neutral position to allow the homeopathists to dominate the content of the article with their bogus (according to mainstream science - and therefore according to Misplaced Pages) position.
- Aside from all of that - you may ask why poor old homeopathy is being called a pseudoscience in the first place? Some see this word as some kind of an insult. It's not, it's a straightforward classification of an idea or discipline. The definition of the word pseudoscience given in most dictionaries agrees with the one provided by Wiktionary, which I'll quote for you:
- Any body of knowledge purported to be scientific or supported by science but which fails to comply with the scientific method.
- Homeopathy undoubtedly purports to be scientific - it makes MANY claims to be able to produce certain results from certain practices based on scientific-sounding descriptions of some very odd properties of water.
- The deciding factor is therefore whether or not homeopathy follows "The Scientific Method".
- I suggest you read at least the introduction to our Scientific method article...but here is a summary of what this means:
- Basically, the scientific method requires that you form an idea which you are not yet certain about. We call that a "hypothesis". A good hypothesis has to explain everything that we already know about the topic and then makes certain testable predictions about the universe. The next step is that you do some experiments to see if those predictions turn out to be true - and if they do, your hypothesis is a better explanation for how the universe works than the one we already have. So you write a paper describing your new hypothesis, what predictions you made, what experiments you did, what results you got and how you interpret those results to back up your hypothesis. This paper is then peer-reviewed for obvious mistakes and deceptions and to be sure that nobody else already showed it was true. That's by a bunch of other people who work in that field ("your peers") - and if it passes muster, it'll be published in some journal or other. If the hypothesis is reasonably compelling, other scientists will attempt to repeat your experiments to see if what you did really works as you claim and they may try to come up with alternative explanations for what you observed. They write more papers - perhaps devise more experiments to test your claims. Eventually, if enough of the other people who test this agree that your hypothesis is the best explanation for the experimental results, your hypothesis becomes accepted into the mainstream as a "theory". (Which is what used to be called a "law").
- So - the burning question here is: Do homeopathists do this? The answer is a blindingly clear "NO!" - they most certainly do not. What they did is to come up with two basic hypotheses:
- Diluting something until there is none left 'imprints' the water in some permanent or at least long-lived fashion.
- Drinking imprinted water affects your health in some manner - possibly the reverse of the harm that would be caused by ingesting the original substance.
- What experiments have been done to follow up on (1)? The answer is - none whatever. Not one single documented example of a homeopathist systematically testing whether water takes on this "imprint" has ever been performed! Where are the double-blind studies of (2)? Where is the statistical analysis of how many people were cured of their colds by very diluted raw duck liver?
- That is why we call homeopathy a "pseudoscience" - it makes scientific claims - but never does the hard work to test them...instead they skip the basic science, skip the human trials and go straight to selling the stuff in little bottles in WalMart.
- Misplaced Pages says that homeopathy is a pseudoscience because that is precisely, and undeniably what it is. This is the mainstream view of scientists - and it clearly follows the definition of the word and what is going on in the world of homeopathy.
- We don't say that religions are pseudosciences because they tell people to take their wild and crazy claims on faith - and (with some exceptions) tend not to make scientific predictions or wrap themselves in the mantle of science. We don't say that quantum physics is pseudoscience because although quantum physicists make scientific claims, they really do follow the scientific method.
Klocek (talk · contribs) - there is a scientific consensus that homoeopathy is pseudoscience, including "in Europe". Barney the barney barney (talk) 13:14, 25 May 2014 (UTC)
- There is no consensus that homeopathy is pseudoscience --24.107.242.181 (talk) 02:40, 2 June 2014 (UTC)
- Yes, there is. Homeopathy with astrology are the textbook case of obvious pseudoscience.--McSly (talk) 02:43, 2 June 2014 (UTC)
- no - you are wrong - look what the best review for oscillo says — Preceding unsigned comment added by 24.107.242.181 (talk) 02:50, 2 June 2014 (UTC)
- While SteveBaker provides an excellent explanation above, the real reason the article includes "Homeopathy is a pseudoscience" is the which (in the article) point to reliable sources that verify the statement. Anyone wanting to contest the statement needs to explain how the sources are incorrectly used, or provide other specific evidence to contradict the statement—bearing in mind that reliable sources are required. Johnuniq (talk) 04:16, 2 June 2014 (UTC)
- Assuming that by "the best review for oscillo" you mean the Cochrane review, it doesn't say anything about whether or not homoeopathy is regarded as pseudoscience, so cannot be used as a source on this point. Brunton (talk) 07:15, 2 June 2014 (UTC)
- Incidentally, if we need more sourcing for this, several of the essays in the book Philosophy of Pseudoscience (ed. Massimo Pigliucci and Maarten Boudry) recently published by the University of Chicago Press use homoeopathy as an example of pseudoscience, for example (p. 30), "Despite the lack of generally accepted demarcation criteria, we find remarkable agreement among virtually all philosophers and scientists that fields like astrology, creationism, homeopathy are either pseudosciences or at least lack the epistemic warrant to be taken seriously", or (p. 49), "homeopathy is a paradigmatic example of pseudoscience". Brunton (talk) 07:41, 2 June 2014 (UTC)
- no - you are wrong - look what the best review for oscillo says — Preceding unsigned comment added by 24.107.242.181 (talk) 02:50, 2 June 2014 (UTC)
- Yes, there is. Homeopathy with astrology are the textbook case of obvious pseudoscience.--McSly (talk) 02:43, 2 June 2014 (UTC)
correcting misrepresentative opinion
The asertion of the UK House of Commons Scientific Select Committee is contentious with regard to the support garnered from within the committe, it noted that only three of those sitting actually voted and of those three none had any specilaist knowledge of the subject. No Health Care Trust at the time were invited to speak neither was representatives from Homeopathic association and not least no patient was afforded the same opportunity. As to the closing Paragraph remark that the government agrees is disingenous especial in light of Observations on the report Evidence Check 2: Homeopathy by the House Of Commons Science and Technology Committee, February 2010,which noted,these limitations make the Committee’s report an unreliable source of evidence about homeopathy. The jury must still be regarded as out on its efficacy and risk/ benefit ratio. Whether more research should be done, and of what kind, is another question. But there can be no ethical objection to it since the principal questions have not, as the Committee claimed, “been settled already”. Earl Baldwin of Bewdley. June 2010. Added to which 206 sitting MPs signed an early day motion expressing concerns over the report content and procedure — Preceding unsigned comment added by 80.2.37.152 (talk) 22:11, 11 June 2014 (UTC)
- It is a direct quote from the report. If you want to have this modified or removed you will have to provide a WP:RS source of equal or greater weight which clearly contradicts the report. What you have provide so far is primarily WP:OR . --Daffydavid (talk) 00:17, 12 June 2014 (UTC)
- That EDM was by David Tredinnick (politician). 'Nuff said. LeadSongDog come howl! 17:04, 15 June 2014 (UTC)
Better Source for Placebo Claim?
The lede makes the strong claim that "its remedies have been found to be no more effective than placebos" yet the cited source is much less committal in its interpretation:
Biases are present in placebo-controlled trials of both homoeopathy and conventional medicine. When account was taken for these biases in the analysis, there was weak evidence for a specific effect of homoeopathic remedies, but strong evidence for specific effects of conventional interventions. This finding is compatible with the notion that the clinical effects of homoeopathy are placebo effects.
Surely there is a better source, that more firmly supports the statement in the lede? I'd rather not back up an assertion that "homeopathic remedies have been found to be no more effective than placebos" with a finding that "there was weak evidence for a specific effect of homeopathic remedies." Most studies I've found online are meta-studies that are themselves based on analysis of earlier studies, many of which were conducted with the intention of proving that homeopathy works. So the meta-studies generally take the approach of finding flaws with the earlier studies, or cross-referencing effects to smooth out differences and reduce the significance of measured effects. I understand why they need to do this (nobody but homeopathy supporters tend to want to fund large-scale studies of homeopathy) but for something that is so widely accepted as pseudoscience among the mainstream medical community, surely there is some primary research with a less wishy-washy demonstration of the placebo claim?
Also, the same source is actually listed twice in the references. I'd try to fix it but the proper syntax for handling citations in Misplaced Pages is.. less than obvious to me. --Pyrrhoneia (talk) 05:36, 12 June 2014 (UTC)
Extremely high dilutions as basically only line of argument against homeopathy over several paragraphs?
Over several paragraphs in the "Evidence and Efficacy" section of the article, homeopathy is dismissed with the sole argument that extremely high dilutions (over D20/C10) statistically leave none of the original substance in the final product:
"The low concentration of homeopathic remedies, which often lack even a single molecule of the diluted substance..."
"The extreme dilutions used in homeopathic preparations often leave none of the original substance in the final product."
"The extremely high dilutions in homeopathy preclude a biologically plausible mechanism of action."
This, of course is statistically true for those extreme dilutions. However, this argumentation (and, I reiterate, this argumentation is basically used as the sole argument in those paragraphs) ignores that most homeopathic medications are usally administered at far lower dilutions (D3 to D12), which do not pose the need to argue with "water memory" or "quantum effects", as even a dilution as high as D12 (X12) still contains roughly 10 substance molecules per mol (14g/0.5oz) of water. I think pointing out the impossible "high" dilutions as the sole line of argumentation while completely ignoring the "lower" dilutions is a structural flaw of those paragraphs and should be adressed. -- megA (talk) 21:58, 12 June 2014 (UTC)
- There is a section discussing high dilution, under the "Plausibility" sub-heading. But it is not by any means the "only line of argument", nor even the major one. There is more emphasis on the lack of reliable evidence for homeopathy's effectiveness. After all, as my grandmother used to say "the proof of the pudding is in the eating". --Gronk Oz (talk) 00:44, 13 June 2014 (UTC)
Gronk Oz, MegA is correct. While there are various other reasons to doubt the claims of homeopathy, they are nonetheless not adequately addressed in the specified paragraphs. MegA's point was about the article, not about homeopathy. This article actually does a pretty terrible job of providing references explaining why homeopathy is considered a pseudoscience. I came here looking for an easily accessible list of such references, but most of the cited sources are meta-studies that actually end up providing weak support for homeopathy rather than refuting it. I understand why that is (they're meta-studies based on primary studies that were attempting to prove homeopathy was effective) but there are good primary studies, if you dig deep enough. They're old and not all of them are online, though. I'm trying to locate them now, but help would be appreciated. --Pyrrhoneia (talk) 06:52, 13 June 2014 (UTC)
For your enjoyment
http://www.change.org/en-IN/petitions/wikipedia-call-to-action-to-update-homeopathy-at-wikipedia Be aware of online petitions! As a fun sidenote, this clearly demonstrate how homeopaths think how science works: By petition.^^Rka001 (talk) 11:36, 14 June 2014 (UTC)
- Why are they calling for "a large number of people sign this petition"? Surely, the less people that sign it, the more effective it will be. ;) AndyTheGrump (talk) 14:46, 14 June 2014 (UTC)
- I got a request to sign a petition from change.org to avoid the Homeopathic section's closure at the Bristol (or was it Glasgow?) Hospital which claimed that a petition for it's closure was signed by 2000 sceptics/critics of Homeopathy, while they have 24,000 signatures to avoid its closure and were looking to make it 25,000 signatures. However, are we at wikipedia going to put such trivia into this article? I hope not!—Khabboos (talk) 14:43, 18 June 2014 (UTC)
Positive studies and clinical trials
STUDIES OF THE ACTIVITY OF HOMEOPATHIC MEDICINES
<tbody> </tbody>ORIGINAL/TRANSLATED TITLE | AUTHOR(S) | PUBLICATION | ACTIVITY | STUDY |
Inhibition of lymphoblast transformation test (LTT) in phytohaemagglutinin (PHA) with Phytolacca americana in homeopathic dilution |
Colas H., Aubin M., Picard P., Lebecq J.C. |
Ann. Homéopat. Fr., 1975, 6: 1-11. |
Inhibitory |
Lymphoblast transformation |
Inquiry into the limits of biological effects of chemical compounds in tissue culture. I. Low dose effects of mercure chloride |
Mansvelt J.D., van Amons E. |
Z. Naturtorschung, 1975, 30: 643-649. |
Inhibitory |
Lymphocyte growth |
The effects of Belladonna and Ferrum phosphoricum on the chemoluminescence of human poly-morphonuclear neutrophils |
Poitevin B., Aubin M., Royer J.F. |
Ann. Homéop. Fr., 1983, 3: 5-12. |
Inhibitory |
Radical release |
Effect of aconitum and veratrum on the isolated perfused heart of the common eel (Anguilla anguilla) |
Pennec J.P., Aubin M. |
Comp. Biochem. Physiol., 1984, 776: 367-369. |
Protective | Aconitine toxicity |
Elements of homeopathic pharmacology |
Aubin M. |
Homéopathie Franç., 1984, 72: 231- 235 |
Protective | Aconitine toxicity |
The effect of homeopathic preparations on the phagocyte activity of granulocytes. In vitro tests and double-blind controlled trials |
Wagner H., Jurcic K., Doenicke A., Rosenhuber E., Behrens N. |
Arzneim. Forsch./Drug Res., 1986, 36: 1424-1425. |
Stimulant | Phagocytosis |
Approach to quantitative analysis of the effect of Apis mellifica on the degranulation of human basophils cultivated in vitro |
Poitevin B., Aubin M., Benveniste J. |
Innov. Tech. Biol. Med., 1986, 7: 64-68. |
Inhibitory |
Basophil degranulation |
In vitro stimulation of human granulocytes and lymphocytes by pico- and femtogram quantities of cytostatic agents |
Wagner H., Kreher B., Jurcic K. |
Arzneim. Forsch./Drug Res., 1988, 38: 273-275. |
Stimulant |
Lymphocyte growth |
In vitro immunological degranulation of human basophils is modulated by lung histamine and Apis mellifica |
Poitevin B., Davenas E., Benveniste J. |
Brit. J. Clin. Pharmacol., 1988, 25: 439-444. |
Inhibitory |
Basophil degranulation |
Cytotoxic agents as immunomodulators |
Wagner H., Kreher B. |
Proc. of the 3rd GIRI meeting, Paris, 1989, 31- 46. |
Stimulant |
Lymphocyte growth |
Contributions of fundamental research in homeopathy |
Boiron J., Belon P. |
Berl. J. Res. Hom., 1990, 1: 34-35. |
Inhibitory |
Basophil degranulation |
Synergism of action between indoleacetic acid (IAA) and highly diluted solutions of CaCO3 on the growth of oat coleoptiles |
Bornoroni C. |
Berl. J. Res. Hom., 1991, 1 (4/5): 275-278. |
Stimulant |
Growth of plant cells |
Study of the action of Hahnemannian dilutions of mercury chloride on the mitotic index in animal cell cultures. |
Boiron J., Abecassis J., Cotte J., Bernard A.M. |
Ann. Homéop. Fr., 1991, 23: 43-49. |
Protective | Hg toxicity |
Dual effects of formylpeptides on the adhesion of endotoxin-primed human neutrophils |
Bellavite P., Chirumbolo S., Lippi G., Andrioli G., Bonazzi L., Ferro I. |
Cell. Biochem. Funct., 1993, 11: 231-239. |
Inhibitory |
Cell adhesion (bact. pept. 10-8-10-9) |
Effects of homeopathic preparations of organic acids and of minerals on the oxidative metabolism of human neutrophils |
Chirumbolo S., Signorini A., Bianchi I., Lippi G., Bellavite P. |
Br. Hom. J., 1993, 82: 227-244. |
Inhibitory |
Leucocyte activation (metabolism) |
Platelets/endothelial cells interactions in presence of acetylsalicylic acid at ultra low dose |
Doutremepuich C., Lalanne M.C., Ramboer I., Sertillanges M.N., De Seze O. |
Omeomed 92 (C. Bornoroni, ed.), 1993, Editrice Compositori, Bologna: 109-115. |
Inhibitory |
Prostacyclin release |
Effect of high dilutions of epidermal growth factor (EGF) on in vitro proliferation of keratinocyte and fibroblast cell lines |
Fougeray S., Moubry K., Vallot N., Bastide M. |
Br. Hom. J., 1993, 82: 124-125. |
Inhibitory |
Growth of keratinocytes |
Effects of different homeopathic potencies of Lachesis on lymphocyte cultures obtained from rabbit blood |
Enbergs H., Arndt G. |
Biol. Tier., 1993, 4. |
Stimulant |
Mitotic and immunostimulating activity (bact. pept 10-5-10-6) |
The effect of homeopathic potencies of housedust mite on the migration of house-dust sensitive human leukocytes |
Gibson S.L., Gibson R.G. |
Complement. Ther. Med., 1996, 4: 169-171. |
Stimulant |
Leucocyte chemotaxis |
The effects of Nux vomica Homaccord and Atropinum comp. on intestinal activity in vitro |
Kanui T.I., Enbergs H. |
Biol. Tier., 1996/1, 43-47. |
Stimulant |
Contraction of intestinal muscles |
Application of flow cytometry to the analysis of the immunosuppressive effect of histamine dilutions on human basophil action: effect of cimetidine |
Sainte-Laudy J., Belon P. |
Inflamm. Res., 1997, 46: S27-S28. |
Inhibitory |
Basophil degranulation |
Effects of Podophillum pellatum compounds in various preparations and dilutions on human neutrophil functions in vitro |
Chirumbolo S., Conforti A., Lussignoli S., Metelmann H. et Al. |
Br. Hom. J., 1997; 86-16. |
Inhibitory |
Release of superoxides |
In vivo and in vitro studies on the efficiency of potentized and nonpotentized substances |
Harisch G., Dittmann J. |
BT, 1997, 2; 40-46. |
Difference between potentised and non-potentised substances |
In vivo and in vitro study; basic research |
Experiments with the effects of Ubichinon-Injeel and strong Ubichinon-Injeel on an acellular system |
Harisch G., Dittmann J. |
BM, 1997, 3; 99-104. |
Different effects of associations of various potencies and individual potencies |
In vitro study; basic research |
Efficacy of the homeopathic drugs Suis and Arnica comp.-Heel® on lymphocyte and phagocyte activity |
Enbergs H. |
BM, 1998, 1; 3-11. |
Effect of organotherapeutics and Arnica comp. - Heel® on immune system cells |
In vitro study; basic research |
Influence of dilutions and potencies of cAMP on different enzymatic systems |
Harisch G., Dittmann J. |
BM, 1998, 2; 55-62. |
Effects of dilutions and potencies of cAMP on some enzymatic activities |
In vitro study; basic research |
Studies of the principles of homeopathy; the changeover from in vivo to in vitro experimental research |
Harisch G., Dittmann J. |
BM, 1998, 3; 98-103. |
Potentised and non-potentised dilutions are equally effective, but have different actions |
Basic research |
Determination of the activity of acid phosphatase with cAMP at various potencies |
Harisch G., Dittmann J. |
BM, 1999, 1; 4-8. |
Different effects on enzymatic activity |
In vitro study; basic research |
Contribution to study of the efficacy of homeopathic potencies of phosphorus |
Gomez J.C. |
BT, 1999, 2; 53-57. |
Effect of different potencies of phosphorus |
Tests on guinea pigs |
Determination of the activity of acid phosphatase in the presence of Ubichinon comp. |
Harisch G., Dittmann J. |
BM, 1999, 4; 188-194. |
Effect of enzymatic activity of homeopathic medicine |
Basic research |
Biochemical efficacy of homeopathic and electronic preparations of D8 potassium cyanate |
Dittmann J., Kanapin H., Harisch G. |
FKM, 1999, 6; 15-18. |
Homeopathic potentisation is more effective than electronic potentisation |
Basic research |
Osteoporosis in vitro in rat tibiaderived osteoblasts is promoted by the homeopathic preparation, FMS Calciumfluor |
Palermo C., Filanti C., Poggi S., Manduca P. |
Cell Biol Int, 1999, 23(1): 31-40. |
Stimulant |
Osteogenesis (trial with compound drug) |
Thin-layer chromatography (TLC) of homeopathic active constituents |
Schmolz M. |
BM, 1999, 5; 248-250. |
Constituents of Arnica comp.- Heel® ointment: electrophoresis accelerates their skin penetration. |
Basic research |
Effect of homeopathic
constituents on enzymaticactivity. |
Basic research | |||
Efficacy of a potentised homeopathic drug in reducing cytotoxic effects produced by arsenic trioxide in mice |
Datta S., Mallick P., Bukhsh A.R. |
Complement Ther Med, 1999 Jan; 7 (8): 62-75 (a). |
Protective |
Arsenic trioxide toxicity |
Efficacy of a potentised homeopathic drug in reducing cytotoxic effects produced by arsenic trioxide in mice |
Datta S., Mallick P., Bukhsh A.R. |
Complement Ther Med, 1999 Sep; 7 (3): 156-63 (b). |
Protective |
Arsenic trioxide toxicity |
Non-cytotoxic antiviral action of a homeopathic drug |
Heine H. |
Ärzteitschrift für Neturheilverfahre, 2000; 41: 542-7. |
Stimulant |
γ interferon synthesis |
Efficacy of a potentised homeopathic drug in reducing cytotoxic effects produced by arsenic trioxide in mice |
Kundu S.N., Mitra K., Khuda Bukhsh A.R. |
Complement Ther Med , 2000 Sep; 1 (3): 157-65. |
Protective |
Arsenic trioxide toxicity |
Stimulatory effect of some plant extracts used in homeopathy on the phagocytosis induced chemiluminescence of polymorphonuclear leukocytes |
Crocnan D., Greabu M., Olinescu R. |
Rocz Akad Med Biochemist, 2000; 45: 246-254. |
Stimulant |
Phagocytosis |
Difference between the efficacy of single potencies and chords |
Dittmann J., Harisch G. |
BM, 2000, 1; 18-23. |
Potency chords are more effective than single potencies |
Basic research |
Influence of some homeopathic drugs on the catalytic activity of uricase, acid phosphatase and the cytosol glutathion-S-transferase |
Dittmann J., Kanapin H., Harisch G. |
BM, 2000, 3; 125-131 |
Effect of D8 potencies on three different enzymatic systems |
Basic research |
Influence of some homeopathic drugs on the catalytic activity of cAMP-dependent protein kinases |
Dittmann J., Kanapin H., Harisch G. |
BM, 2000, 6; 289-296. |
Effect of different potencies of 5 substances on enzymatic activity |
Basic research |
Neuroprotection from glutamate toxicity with ultra-low dose glutamate |
Jonas W., Lin Y., Zortella F. |
Neuroreport, 2001 Feb 92; 12 (2): 335-9. |
Protective | Glutamate toxicity |
KEY: BT = Biomedical Therapy
BM = Biologische Medizin
FKM = Forschung Komplementär Medizin
Categories:
- Pseudoscience articles under contentious topics procedure
- Misplaced Pages controversial topics
- Delisted good articles
- Former good article nominees
- Old requests for peer review
- All unassessed articles
- B-Class Skepticism articles
- High-importance Skepticism articles
- WikiProject Skepticism articles
- WikiProject templates with unknown parameters
- B-Class Alternative medicine articles
- B-Class Alternative views articles
- High-importance Alternative views articles
- WikiProject Alternative views articles
- B-Class medicine articles
- Mid-importance medicine articles
- All WikiProject Medicine pages